Rezultati pretraživanja
  1. 12. stu 2019.

    Not all funding is created equal – learn about non-dilutive $ sources and how you might get them at on Dec. 3rd. Register now

  2. 4. lis 2019.

    resident Entos announces a new partnership! Their Fusogenix drug delivery platform will be used to develop nex gen therapies for inflammatory & autoimmune diseases

  3. In step with the rapid transformation of startup business models, seed financing continues to evolve. Join Head Sanjay Mistry today to learn more about key changes that can impact life science innovators in 2020.

  4. 29. sij

    It’s almost time! Tomorrow, come meet the team and learn about joining the JLABS @ San Diego community. See you there:

  5. 23. tra 2019.

    Congratulations to Avidity Biosciences, a alumni, on their $35M research and licensing collaboration for their antibody-oligonucleotide technology! Under the new deal, they could receive additional funds of up to $405M in…

  6. 22. svi 2019.

    50% chance of showers, 100% chance of funds - resident Locana announces a $55M series A round for their RNA targeting

  7. 12. pro 2019.
  8. 27. sij

    Creating potentially life changing science is hard work – but, you don’t have to do it alone! Get a feel for what it’s like to be part of the community & meet the team 1/29 👉

  9. 9. lis 2019.

    📣 Got a speech coming up soon? Get an insider tip from in link below 👇 Don't forget to be there in person for program 10.17 Register:

  10. 4. stu 2019.

    DYK almost 2x as many women die of lung cancer than breast cancer? * gathers leading researchers & innovators to talk breakthrough innovations 11/14 *source:

  11. 1. srp 2019.

    From a handful companies at the start of in 2012, to 560+ globally today – reflects on the purpose & impact of on the innovation ecosystem in San Diego and beyond

  12. 24. ruj 2019.

    Congratulations resident, Phoenix Molecular Designs who received clearance to enter Phase 1/1b clinical trials for PMD-026 an RSK inhibitor targeting advanced ,read more:

  13. 13. stu 2019.

    Fall funding news for Avidity Biosciences - $100M raised to advance pioneering science to treat rare muscle disorders Troy Wilson is a terrific founder and now Sarah Boyce as CEO.

  14. Is your startup advancing science that could prevent biological, chemical or infectious disease threats? Apply to meet with by 9/5:

  15. 3. pro 2019.

    Should you hire a grant writer? ✏️ Opinions are mixed - a good strategy is to write the grant yourself (nobody knows the science better!) and have an external advisor do a mock review

  16. Sanjay Mistry highlights incubation model is no strings attached, offering mentorship, expertise, & a “community of companies” of shared learning among residents.

  17. 8. ožu 2019.

    alumni, Oncternal Therapeutics announces merger w/publicly traded co, GTx. The combined company will develop potential 1st in class therapeutics for cancers

  18. prije 14 sati

    Are you weighing the options of debt vs. equity in your startup’s finance strategy? Hear from experts from Correlation Ventures, Avidity Biosciences & SVB 2.27

  19. prije 16 sati

    Who will win in the battle of debt vs equity? Join the fight on 02.27 at 👀🥊

  20. 4. velj

    Greetings from 's pitch fest! 's CEO Marilyn Bruno is pitching our innovative that can fight , increase of algae by over 40%, and combat .

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.